We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Essex Property Trust
ESS
$18.3B
| – | – |
-1,418
| Closed | -$203K |
|
902
Eaton
ETN
$161B
| – | – |
-4,576
| Closed | -$349K |
|
903
Evercore
EVR
$12.4B
| – | – |
-3,539
| Closed | -$212K |
|
904
CALL
Edwards Lifesciences
EW
$49.6B
| – | – |
-12,036
| Closed | -$672K |
|
905
Exelixis
EXEL
$13.3B
| – | – |
-1,200,000
| Closed | -$7.36M |
|
906
Expeditors International
EXPD
$22B
| – | – |
-4,865
| Closed | -$215K |
|
907
First American
FAF
$7.66B
| – | – |
-10,454
| Closed | -$295K |
|
908
Fastenal
FAST
$54.7B
| – | – |
-18,952
| Closed | -$225K |
|
909
Factset
FDS
$9.36B
| – | – |
-2,606
| Closed | -$283K |
|
910
Flowserve
FLS
$9.71B
| – | – |
-533,625
| Closed | -$8.56M |
|
911
Fidelity National Financial
FNF
$13.9B
| – | – |
-19,218
| Closed | -$356K |
|
912
H.B. Fuller
FUL
$2.97B
| – | – |
-13,419
| Closed | -$698K |
|
|
GDL
913
GDL Fund
GDL
$91.6M
| – | – |
-22,748
| Closed | -$250K |
|
914
Gen Digital
GEN
$16.4B
| – | – |
-26,663
| Closed | -$629K |
|
915
Gerdau
GGB
$9.74B
| – | – |
-630,000
| Closed | -$3.92M |
|
|
GLO
916
Clough Global Opportunities Fund
GLO
$250M
| – | – |
-40,187
| Closed | -$525K |
|
|
GLQ
917
Clough Global Equity Fund
GLQ
$152M
| – | – |
-14,515
| Closed | -$229K |
|
|
GLV
918
Clough Global Dividend & Income Fund
GLV
$78.1M
| – | – |
-21,578
| Closed | -$331K |
|
919
GameStop
GME
$9.75B
| – | – |
-588,152
| Closed | -$7.24M |
|
920
Hyatt Hotels
H
$16.4B
| – | – |
-4,411
| Closed | -$218K |
|
921
Haemonetics
HAE
$3.89B
| – | – |
-60,058
| Closed | -$2.53M |
|
922
Helix Energy Solutions
HLX
$1.4B
| – | – |
-132,159
| Closed | -$3.06M |
|
923
Hormel Foods
HRL
$13.8B
| – | – |
-14,946
| Closed | -$338K |
|
924
Hilltop Holdings
HTH
$2.26B
| – | – |
-8,705
| Closed | -$201K |
|
925
Hexcel
HXL
$7.79B
| – | – |
-87,144
| Closed | -$3.89M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.